Will there finally be a chance to invest in SpaceX stock in 2015?
When Intel Corp. (Nasdaq: INTC) reports its third-quarter earnings after the market close today (Tuesday), the world's largest chipmaker should get a boost from the improving PC market.
The Q3 INTC earnings will also tell investors whether Santa Clara, Calif.-based Intel has been able to make any headway in its lagging mobile business. In addition, we'll learn whether its one-year-old Internet of Things initiative is still on track.
If you want to know why the gold price today slipped off Monday's four-week high, here's all you need to know…
The current downdraft in stock prices has understandably set the happy faces on CNBC running for cover as they try to figure out what went wrong.
After all, the U.S. economy is growing and the Federal Reserve has made it clear that interest rates won't be raised until the middle of next year. How could stocks have the temerity to sell off?
After last week's gyrations, the Standard and Poor's 500 Index is down 5.5% from its September highs – more than halfway to a stock market correction of about 10%.
But Money Morning Chief Investment Strategist Keith Fitz-Gerald — a seasoned market analyst with 33 years of experience – refuses to go along with the gloom-and-doom crowd that's now predicting a stock market crash of 20% to 30%.
In fact, not even a 10% stock market correction bothers him.
To find out why Fitz-Gerald would relish a stock market correction, watch this video.
The bears are out in full force trumpeting the news that there's a tech bubble, and the steep decline has started.
As of today's opening, the Nasdaq Composite has dropped 7.3% in just over three weeks. That drop followed an incredible run where the index climbed 28% from September 2013 through September 2014.
But according to Money Morning experts, this is unequivocally not a tech bubble.
There are more than 1,000 biotech companies in North America alone. They cover a wide range of sectors including pharmaceuticals, biologics, generics, and medical devices.
But finding the right stocks in such a broad industry is no easy task.
That's why we've targeted the best biotech ETF to buy now. It offers investors an excellent way to play the entire industry, without having to pick a specific sector.
Multinational stocks have started to feel some negative ripple effects of the rising U.S. dollar index.
While a rising U.S. dollar index can have benefits, companies with a lot of global business face reduced sales and profits as their goods grow more expensive. For U.S. companies with substantial overseas sales, this means an extended period of pain.
Last week's Dow Jones Industrial Average performance is yet another reason to buy dividend-paying stocks. Market volatility moved the index nearly 1,000 points.
Ned Davis Research shows that stocks that pay dividends tend to fall less than broader markets during corrections.
If you couldn't get a piece of the largest IPO in history a couple of weeks ago, you weren't alone.
The Alibaba IPO will go down as the greatest wealth opportunity of a generation – but only about 4% of the $25 billion worth of stock went to individual investors.